Table 2.

Biological characteristics of dendritic cells used for vaccination

	iDC median % (range)	mDC median % (range)
DC surface markers:
CD 1a	20 (4–58)	2 (0–8)
CD 14	3 (0–7)	2 (0–11)
CD 80	3 (1–23)	37 (27–87)
CD 86	30 (10–55)	81 (15–94)
HLA-DR	45 (17–82)	78 (56–88)
CD 83	2 (0–13)	55 (34–73)
CCR7	4 (2–5)	86 (48–92)
Endocytosis % of positive cells	70 (39–91)	15 (1–42)
IL-12 production pg/ml	49 (17–225)	> 1350
IL-10 production pg/ml	0	0
% purity *	74 (66–98)	59 (31–100)
% vitality **	75 (68–79)	82 (66–89)

* viable DC/viable DC + viable lymphocytes ** viable DC + viable lymphocytes/total cells